fda ruling on tirzepatide today says shortage of GLP-1 drug is over FDA reviews decision to put

Bowers et al

Clinical Uses: Nausea & vomiting (postoperative, drug-induced, migraine-associated) Diabetic gastroparesis Gastroesophageal reflux disease (GERD) Facilitation of small-bowel intubation Adverse Effects: Extrapyramidal symptoms (EPS) such as dystonia, tremors Drowsiness, restlessness Long-term use Tardive dyskinesia Contraindicated in Parkinsons disease & bowel obstruction Clinical Tip: Use short-term (12 weeks) when possible

Retrieved 2022-10-11

either in the form of parenteral artificial nutrition solutions (carbohydrates, amino acids, peptides, lipids, electrolytes, trace elements, vitamins)